At the beginning of tumor genesis, IL-10 might predominantly act as a antitumor factor by potentiating the cytotoxicity of NK cells and CTLs to tumor cells; while with the progression of tumor, IL-10 might mainly act as a potent tumor promoter via the IL-10R expressed on tumor cells (14). The gene discussed is IL10; the disease is neoplasm.